MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2

Biochemical and Biophysical Research Communications

Volumn 447, Issue 3, 2014, Pages 446-451

  Xia, Ying ^a   Gao, Yan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Invasion; LATS2; MiR 181b; Ovarian cancer; Proliferation

Indexed keywords

MICRORNA; MICRORNA 181B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LATS2 GENE; OVARY CANCER; PRIORITY JOURNAL; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION;

INVASION; LATS2; MIR-181B; OVARIAN CANCER; PROLIFERATION;

3' UNTRANSLATED REGIONS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84900330100     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.04.027     Document Type: Article

References (31)

1. Chuffa L.G., Fioruci-Fontanelli B.A., Mendes L.O., Fávaro W.J., Pinheiro P.F., Martinez M., Martinez F.E. Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment. PLoS One 2013, 8:e81676.
2. Zhang Z., Zhou B., Wu Y., Gao Q., Zhang K., Song Y., Zhang L., Xi M. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population. Immunogenetics 2014, 66:85-92.
3. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013, CA. Cancer J. Clin. 2013, 63:11-30.
4. Hirata H., Ueno K., Shahryari V., Deng G., Tanaka Y., Tabatabai Z.L., Hinoda Y., Dahiya R. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One 2013, 8:e55502.
5. Huang S., Chen Y., Wu W., Ouyang N., Chen J., Li H., Liu X., Su F., Lin L., Yao Y. MiR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor. PLoS One 2013, 8:e80707.
6. Yabuta N., Fujii T., Copeland N.G., Gilbert D.J., Jenkins N.A., Nishiguchi H., Endo Y., Toji S., Tanaka H., Nishimune Y., Nojima H. Structure, expression, and chromosome mapping of LATS2, a mammalian homologue of the Drosophila tumor suppressor gene lats/warts. Genomics 2000, 63:263-270.
7. Yu F.X., Guan K.L. The Hippo pathway: regulators and regulations. Genes Dev. 2013, 27:355-371.
8. Ke H., Pei J., Ni Z., Xia H., Qi H., Woods T., Kelekar A., Tao W. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L). Exp. Cell Res. 2004, 298:329-338.
9. Murakami H., Mizuno T., Taniguchi T., Fujii M., Ishiguro F., Fukui T., Akatsuka S., Horio Y., Hida T., Kondo Y., Toyokuni S., Osada H., Sekido Y. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011, 71:873-883.
10. Zhang K., Rodriguez-Aznar E., Yabuta N., Owen R.J., Mingot J.M., Nojima H., Nieto M.A., Longmore G.D. Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation. EMBO J. 2012, 31:29-43.
11. Zhang Y., Yang J., Cui X., Chen Y., Zhu V.F., Hagan J.P., Wang H., Yu X., Hodges S.E., Fang J., Chiao P.J., Logsdon C.D., Fisher W.E., Brunicardi F.C., Chen C., Yao Q., Fernandez-Zapico M.E., Li M. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol. Med. 2013, 5:1322-1334.
12. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012, CA. Cancer J. Clin. 2012, 62(2012):10-29.
13. Schickel R., Boyerinas B., Park S.M., Peter M.E. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008, 27:5959-5974.
14. Wang M., Li C., Yu B., Su L., Li J., Ju J., Yu Y., Gu Q., Zhu Z., Liu B. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J. Gastroenterol. 2013, 48:1023-1033.
15. Yang J., Liu H., Wang H., Sun Y. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Pathol. Res. Pract. 2013, 209:490-494.
16. Parikh A., Lee C., Peronne J., Marchini S., Baccarini A., Kolev V., Romualdi C., Fruscio R., Shah H., Wang F., Mullokandov G., Fishman D., D'Incalci M., Rahaman J., Kalir T., Redline R.W., Brown B.D., Narla G., DiFeo A. MicroRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat. Commun. 2014, 5:2977.
17. Li Y., Wang H., Li J., Yue W. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7. Acta Biochim. Biophys. Sin. (Shanghai) 2014, 46:48-55.
18. Wang X.F., Shi Z.M., Wang X.R., Cao L., Wang Y.Y., Zhang J.X., Yin Y., Luo H., Kang C.S., Liu N., Jiang T., You Y.P. MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. J. Cancer Res. Clin. Oncol. 2012, 138:573-584.
19. Xi Y., Formentini A., Chien M., Weir D.B., Russo J.J., Ju J., Kornmann M., Ju J. Prognostic values of microRNAs in colorectal cancer. Biomarker Insights 2006, 2:113-121.
20. Mansueto G., Forzati F., Ferraro A., Pallante P., Bianco M., Esposito F., Iaccarino A., Troncone G., Fusco A. Identification of a new pathway for tumor progression: MICRORNA-181b up-regulation and CBX7 down-regulation by HMGA1 protein. Genes Cancer 2010, 1:210-224.
21. Wang B., Hsu S.H., Majumder S., Kutay H., Huang W., Jacob S.T., Ghoshal K. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 2010, 29:1787-1797.
22. Yang L., Wang Y.L., Liu S., Zhang P.P., Chen Z., Liu M., Tang H. MiR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells. FEBS Lett. 2014, 588:124-130.
23. He L., Yao H., Fan L.H., Liu L., Qiu S., Li X., Gao J.P., Hao C.Q. MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3. Genet. Mol. Res. 2013, 12:1012-1021.
24. Shi L., Cheng Z., Zhang J., Li R., Zhao P., Fu Z., You Y. Hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008, 1236:185-193.
25. Shi Z.M., Wang X.F., Qian X., Tao T., Wang L., Chen Q.D., Wang X.R., Cao L., Wang Y.Y., Zhang J.X., Jiang T., Kang C.S., Jiang B.H., Liu N., You Y.P. MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas. RNA 2013, 19:552-560.
26. Cooke I.E., Shelling A.N., Le Meuth V.G., Charnock M.L., Ganesan T.S. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Genes Chromosomes Cancer 1996, 15:223-233.
27. Theile M., Seitz S., Arnold W., Jandrig B., Frege R., Schlag P.M., Haensch W., Guski H., Winzer K.J., Barrett J.C., Scherneck S. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 1996, 13:677-685.
28. Li Y., Pei J., Xia H., Ke H., Wang H., Tao W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 2003, 22:4398-4405.
29. Liu X., Sempere L.F., Ouyang H., Memoli V.A., Andrew A.S., Luo Y., Demidenko E., Korc M., Shi W., Preis M., Dragnev K.H., Li H., Direnzo J., Bak M., Freemantle S.J., Kauppinen S., Dmitrovsky E. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J. Clin. Invest. 2010, 120:1298-1309.
30. Lin C.W., Chang Y.L., Chang Y.C., Lin J.C., Chen C.C., Pan S.H., Wu C.T., Chen H.Y., Yang S.C., Hong T.M., Yang P.C. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat. Commun. 2013, 4:1877.
31. Fang L., Du W.W., Yang W., Rutnam Z.J., Peng C., Li H., O'Malley Y.Q., Askeland R.W., Sugg S., Liu M., Mehta T., Deng Z., Yang B.B. MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 2012, 11:4352-4365.